Tranexamic acid

Generic Name
Tranexamic acid
Brand Names
Cyklokapron, Lysteda
Drug Type
Small Molecule
Chemical Formula
C8H15NO2
CAS Number
1197-18-8
Unique Ingredient Identifier
6T84R30KC1
Background

Tranexamic acid is a synthetic derivative of lysine used as an antifibrinolytic in the treatment and prevention of major bleeding. It possesses a similar mechanism of action to aminocaproic acid but is approximately 10-fold more potent.

It was first patented in 1957 and received its initial US approval in 1986.

Indication

Taken orally, tranexamic acid is indicated for the treatment of hereditary angioedema, cyclic heavy menstrual bleeding in premenopausal females, and other instances of significant bleeding in the context of hyperfibrinolysis. Given intravenously, tranexamic acid is indicated for short-term use (2-8 days) in patients with hemophilia to prevent or reduce bleed...

Associated Conditions
Bleeding, Heavy Menstrual Bleeding, Hereditary Angioedema (HAE)
Associated Therapies
-

Tranexamic Acid's Effects in Patients Undergoing Laparoscopic Radical Prostatectomy

Phase 3
Not yet recruiting
Conditions
Interventions
First Posted Date
2023-04-18
Last Posted Date
2023-04-18
Lead Sponsor
Instituto do Cancer do Estado de São Paulo
Target Recruit Count
122
Registration Number
NCT05816668

Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women with Placenta Previa

First Posted Date
2023-04-13
Last Posted Date
2024-10-31
Lead Sponsor
Guangzhou Medical University
Target Recruit Count
1680
Registration Number
NCT05811676
Locations
🇨🇳

Huadu District People's Hospital of Guangzhou, Guangzhou, China

🇨🇳

The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

🇨🇳

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

and more 24 locations

Impact of Topical Tranexamic Acid in Breast Reconstruction

Phase 4
Active, not recruiting
Conditions
Interventions
First Posted Date
2023-04-10
Last Posted Date
2024-12-13
Lead Sponsor
University of California, San Francisco
Target Recruit Count
23
Registration Number
NCT05807074
Locations
🇺🇸

University of California, San Francisco, San Francisco, California, United States

Tranexamic Acid in Rhinoplasty: Perioperative Bleeding, Edema and Ecchymosis

Phase 1
Recruiting
Conditions
Interventions
First Posted Date
2023-03-20
Last Posted Date
2024-02-28
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
60
Registration Number
NCT05774717
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Tranexamic Acid (TXA) in Hip Arthroscopy

First Posted Date
2023-02-02
Last Posted Date
2023-02-02
Lead Sponsor
Northwestern University
Registration Number
NCT05710146
Locations
🇺🇸

Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

Tranexamic Acid During Upper GI Endoscopic Resection Procedures

First Posted Date
2023-01-18
Last Posted Date
2023-08-09
Lead Sponsor
Assaf-Harofeh Medical Center
Target Recruit Count
200
Registration Number
NCT05688020
Locations
🇮🇱

Shamir Medical Center, Be'er Ya'aqov, Israel

The Role of Local Tranexamic Acid on Periorbital Oculoplastic Surgery

First Posted Date
2023-01-05
Last Posted Date
2023-09-21
Lead Sponsor
University of Miami
Registration Number
NCT05672407

Anti-fibrinolytic and Anti-inflammatory Effects of Local Infiltration of Tranexamic Acid in Patients With Calcaneal Fractures

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2022-10-28
Last Posted Date
2022-10-28
Lead Sponsor
Hebei Medical University Third Hospital
Target Recruit Count
113
Registration Number
NCT05598086
Locations
🇨🇳

Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China

Tranexamic Acid to Prevent Heavy Bleeding After Childbirth in Women at Higher Risk

Phase 3
Recruiting
Conditions
Interventions
First Posted Date
2022-10-03
Last Posted Date
2024-04-25
Lead Sponsor
London School of Hygiene and Tropical Medicine
Target Recruit Count
30000
Registration Number
NCT05562609
Locations
🇹🇿

Mbeya Regional Referral Hospital, Mbeya, Tanzania

Tranexamic Acid Usage in Bilateral Mastectomy to Reduce Post-surgical Drainage

First Posted Date
2022-09-26
Last Posted Date
2023-09-18
Lead Sponsor
Northwestern University
Target Recruit Count
30
Registration Number
NCT05554211
Locations
🇺🇸

AMITA Health Saint Joseph Chicago, Chicago, Illinois, United States

🇺🇸

Northwestern Memorial Hospital, Chicago, Illinois, United States

© Copyright 2024. All Rights Reserved by MedPath